Ventricular arrhythmia

1. Stellate ganglion block decreases ventricular arrhythmia in humans (92% (106/115) achieved a ≥50% reduction in arrhythmia burden).

   Reviewin patients with treatable arrhythmic episodes12 hn = 131

   Advances in the clinical application of stellate ganglion block for non-pain indications · Frontiers in medicine · 19 Aug 2026

Stellate ganglion block →

1. C-reactive protein raises the risk of ventricular arrhythmia in humans.

   Humanswithout structural heart disease

   Cardiometabolic and Inflammatory Predictors of Life-Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases · Journal of the American Heart Association · 18 Sep 2026

C-reactive protein →

1. Low-density lipoprotein cholesterol lowers the risk of ventricular arrhythmia in humans (HR 0.89, 95% CI 0.82-0.97).

   Humanswithout structural heart disease

   Cardiometabolic and Inflammatory Predictors of Life-Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases · Journal of the American Heart Association · 18 Sep 2026

Low-density lipoprotein cholesterol →

1. Smoking raises the risk of ventricular arrhythmia in humans (HR 1.78, 95% CI 1.48-2.13).

   Humanswithout structural heart disease

   Cardiometabolic and Inflammatory Predictors of Life-Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases · Journal of the American Heart Association · 18 Sep 2026

Smoking →

1. Hypertension raises the risk of ventricular arrhythmia in humans (HR 2.21, 95% CI 1.90-2.57).

   Humanswithout structural heart disease

   Cardiometabolic and Inflammatory Predictors of Life-Threatening Ventricular Arrhythmias in Adults Without Structural Heart Diseases · Journal of the American Heart Association · 18 Sep 2026

Hypertension →